It has previously been shown that astrocytomas [104] have decreased SFRP3 expression in the nucleus, finding that positively correlates with increasing astrocytoma grade; whereas in the cytoplasm the increase in SFRP3 protein expression was associated with higher grade astrocytomas. Here, FRZB is linked to astrocytoma (excluding glioblastoma).